TDG Syndication

Audi CEO faces backlash after joining Trump at midterm campaign rally

Audi CEO faces backlash after joining Trump at midterm campaign rally

By Rachel More and Christina Amann BERLIN, Oct 26 (Reuters) - Audi chief Gernot Doellner drew heavy criticism on Monday…

October 27, 2026

Anthropic's IPO: A close look at AI frontrunner's rapid growth, spiraling costs

By Deborah Mary Sophia Oct 26 (Reuters) - Anthropic unveiled its US initial public offering paperwork on Monday, setting up…

October 27, 2026

Actor Walter Koenig, 'Star Trek's' plucky Chekov, dies at 90

Oct 26 (Reuters) - Walter Koenig, who brought humor and grit to the role of starship navigator Pavel Chekov on…

October 26, 2026

PRECIOUS-Gold rises as lower oil prices ease inflation fears ahead of Fed meeting

* Oil prices ease from near six-month highs * Fed interest rate decision due on Wednesday * US PCE data…

October 26, 2026

Thomas van Tonder navigates 600 monkey bars over 280 metres in historic crossing

VIDEO SHOWS: THOMAS VAN TONDER BECOMES THE FIRST PERSON TO CROSS 600 MONKEY BARS SUSPENDED BENEATH A BRIDGE, TAKING ON…

October 26, 2026

RGIPT Celebrates 10th Convocation, Showcases Progress in Research, Innovation and Industry Collaboration

Bengaluru (Karnataka) [India], October 26: The Rajiv Gandhi Institute of Petroleum Technology (RGIPT), an Institution of National Importance under the…

October 26, 2026

Boeing forecast to post small quarterly loss despite recent wins, analysts say

By Dan Catchpole SEATTLE, Oct 26 (Reuters) - Despite a flurry of wins for Boeing in recent months, Wall Street…

October 26, 2026

Cadence unveils suite of AI models that chipmakers can run in-house

By Stephen Nellis SAN FRANCISCO, Oct 26 (Reuters) - Cadence Design Systems on Monday launched a portfolio of AI models…

October 26, 2026

US singer Chris Brown spared immediate jail sentence for UK affray charge

LONDON, Oct 26 (Reuters) - US singer Chris Brown was spared an immediate prison sentence in Britain on Monday for…

October 26, 2026

BRIEF-Merck Says Keytruda Cuts Risk of Progression or Death by 43% in dMMR Endometrial Cancer

Oct 26 (Reuters) - Merck & Co Inc: * KEYTRUDA® (PEMBROLIZUMAB) AS MONOTHERAPY REDUCED THE RISK OF DISEASE PROGRESSION OR…

October 26, 2026